" Dr. Ichim has been responsible for 3 FDA cleared Investigational New Drug (IND) Applications in the area of cellular therapy and is inventor of over 100 patents and patent applications."
There main drug of course Caverstemâ„¢ Stem Cell Procedure is now going through commercialization and is set to generate revenue this year. This will be a revolutionary year for this QB OTC company and is entering a field worth billions! At these prices it is well worth getting in as we are sitting near all time lows. This was .70 just a year ago and only a fool would not get in at these levels. This is a research company and it is clear they have a bright future for both investors and the company itself. 33% of people cannot use current ED methods and this solves that problem which could generate billions and if you add that with the other cures they are researching this is a hidden diamond!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.